January 2024

SHANGHAI, Jan. 29, 2024 /PRNewswire/ — Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced the first-tim

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: